Medicine News and Research

RSS

Clot busting drug combo reduces risk of major strokes in high risk patients

In patients who have had a minor stroke or a transient ischemic stroke (TIA), the risk of getting a full-blown stroke or a major stroke is high. A new study has found that these high-risk individuals, when prescribed with clot-preventing drugs clopidogrel along with aspirin show a lower risk of getting major stroke.

18 May 2018

New project aims to increase awareness among hospital clinicians of non-beneficial treatment at end-of-life

Advances in medicine mean health care professionals can prolong life, yet some treatments have a low chance of providing tangible benefits to some patients, can result in a 'bad death' and represent a multi-million dollar cost to the public purse.

18 May 2018

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

A software tool to automatically calculate how extensively bones have been infiltrated by prostate cancer is both accurate and speedy, capturing key prognostic information related to survival and the development of symptoms over time.

17 May 2018

Study provides insights into how immune cells kill bacteria with acid

The first line of immune defense against invading pathogens like bacteria are macrophages, immune cells that engulf every foreign object that crosses their way. After enclosing it in intracellular membrane vesicles, a process called phagocytosis, macrophages kill their prey with acid.

17 May 2018

Drug combination may prevent secondary stroke in certain patients, study shows

Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days.

17 May 2018

Antibacterial substance found in toothpaste may fight against life-threatening lung disease

Michigan State University researchers have found that when triclosan, a substance that reduces or prevents bacteria from growing, is combined with an antibiotic called tobramycin, it kills the cells that protect the CF bacteria, known as Pseudomonas aeruginosa, by up to 99.9 percent.

17 May 2018

New treatment regimen boosts survival for young adults and children with T-cell malignancies

In a federally funded, randomized phase III clinical trial performed by the Children's Oncology Group (COG), 90% of children and young adults with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL) were alive four years after starting treatment regimens on this trial, and 84% were cancer free.

17 May 2018

Sleep deprivation study to pinpoint brain processes causing poor decision-making

Sleep deprivation can take a heavy toll on our ability to make sound decisions, with potentially disastrous outcomes.

17 May 2018

Pancreatic cancer patients with BRCA1 or BRCA2 mutations fare better on platinum-based chemotherapy

A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations.

17 May 2018

Scientists find how immune system helps to clear HBV infection after treatment interruption

Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption.

17 May 2018

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

Rocket Pharmaceuticals, Inc., a leading U.S.-based multi-platform gene therapy company, and the Stanford University School of Medicine today announced a strategic collaboration to support the advancement of Fanconi Anemia and Pyruvate Kinase Deficiency gene therapy research.

17 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

Scientists discover how unusually long strands of RNA help colon cancer cells avoid death

Researchers from Case Western Reserve University School of Medicine have discovered how unusually long strands of RNA help colon cancer cells avoid death, allowing unregulated growth.

17 May 2018

Doctors publish comprehensive proposal to ensure universal access to safe, affordable medications

The skyrocketing cost of prescription drugs is one of the biggest concerns for American voters. However, in his proposal last Friday, President Donald Trump failed to offer any new policies that would expand access, reduce costs, or increase the safety and efficacy of prescriptions.

17 May 2018

Medicine News and Research

Clot busting drug combo reduces risk of major strokes in high risk patients

New project aims to increase awareness among hospital clinicians of non-beneficial treatment at end-of-life

Automated bone scan index offers accurate, speedy prognostic information about prostate cancer

Study provides insights into how immune cells kill bacteria with acid

Drug combination may prevent secondary stroke in certain patients, study shows

Antibacterial substance found in toothpaste may fight against life-threatening lung disease

New treatment regimen boosts survival for young adults and children with T-cell malignancies

Sleep deprivation study to pinpoint brain processes causing poor decision-making

Pancreatic cancer patients with BRCA1 or BRCA2 mutations fare better on platinum-based chemotherapy

Scientists find how immune system helps to clear HBV infection after treatment interruption

Rocket Pharma partners with Stanford University to advance FA and PKD gene therapy research

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Scientists discover how unusually long strands of RNA help colon cancer cells avoid death

Doctors publish comprehensive proposal to ensure universal access to safe, affordable medications

Expectant mothers may use RA drugs without increased health risks to unborn babies

International study finds viable treatment option for people with mild asthma

New study reveals the extent of brain damage due to elevated homocysteine

Comprehensive care physician model reduces hospitalization and expense for high risk patients

Researchers push science one step closer to growing body parts in a lab

New AI software accurately identifies commonest cause of stroke and dementia

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News